Federal Register / Vol. 62, No. 236 / Tuesday, December 9, 1997 / Notices 64853

Dated: December 2, 1997.

Marvin Kalt,

Director, Division of Extramural Activities,

National Cancer Institute.

[FR Doc. 97–32089 Filed 12–8–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Cancer Institute Special

Emphasis Panel (SEP) meeting:

Name of SEP: SBIR Phase I—Innovative

Approaches to Clinical Trials 1 Informatics

(Telephone Conference Call).

Date: December 15, 1997.

Time: 2:30 p.m. to Adjournment.

Place: National Cancer Institute, Executive

Plaza North, Conference Room 640, 6130

Executive Boulevard, Bethesda, MD 20892.

Contact Person: Wilna Woods, Ph.D.,

Scientific Review Administrator, National

Cancer Institute, NIH, Executive Plaza North,

Room 622B, 6130 Executive Boulevard, MSC

7405, Bethesda, MD 20892–7405, Telephone:

301/496–7903.

Purpose/Agenda: To review, discuss and

evaluate responses to Request for Proposal.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

The meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Proposals and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material and

personal information concerning individuals

associated with the proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control)

Dated: December 2, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–32090 Filed 12–8–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Allergy and

Infectious Diseases Special Emphasis

Panel (SEP) meeting:

Name of SEP: Unsolicited R01 (Telephone

Conference Call).

Date: December 16, 1997.

Time: 12:00 p.m. to Adjournment.

Place: Teleconference, 6003 Executive

Boulevard, Solar Building, Room 4C01,

Bethesda, MD 20892, (301) 496–2550.

Contact Person: Dr. Dennis Lang, Scientific

Review Adm., 6003 Executive Boulevard,

Solar Bldg., Room 4C16, Bethesda, MD

20892, (301) 496–2550.

Purpose/Agenda: To evaluate a grant

application.

The meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

Dated: December 2, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–32087 Filed 12–8–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute on Drug Abuse

(NIDA) Special Emphasis Panel

meetings.

Purpose/Agenda: To review and evaluate

grant applications and contract proposals.

Name of Committee: NIDA Special

Emphasis Panel (Contract Review—‘‘InternetBased Research Support for Drug Abuse

Researchers’’).

Date: December 10, 1997.

Time: 9:00 a.m.

Place: Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, MD 20814.

Contact Person: Mr. Lyle Furr, Contract

Review Specialist, Office of Extramural

Program Review, National Institute on Drug

Abuse, 5600 Fishers Lane, Room 10–42,

Rockville, MD 20857, Telephone (301) 443–

1644.

Name of Committee: NIDA Special

Emphasis Panel (Contract Review—

‘‘Development of a Computerized

Neuropsychological Testing Programs’’).

Date: December 17, 1997.

Time: 9:00 a.m.

Place: Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, MD 20814.

Contact Person: Mr. Lyle Furr, Contract

Review Specialist, Office of Extramural

Program Review, National Institute on Drug

Abuse, 5600 Fishers Lane, Room 10–42,

Rockville, MD 20857, Telephone (301) 443–

1644.

Name of Committee: NIDA Special

Emphasis Panel (Contract Review)—

‘‘Analytical Techniques Programs’’).

Date: December 19, 1997.

Time: 11:30 a.m.

Place: National Institute on Drug Abuse,

NIH, 5600 Fishers Lane, Room 10–49,

Rockville, MD 20857.

Contact Person: Mr. Eric Zatman, Contract

Review Specialist, Office of Extramural

Program Review, National Institute on Drug

Abuse, 5600 Fishers Lane, Room 10–42,

Rockville, MD 20857, Telephone (301) 443–

1644.

This notice is being published less than 15

days prior to the meetings due to the urgent

need to meet timing limitations imposed by

the review and funding cycle.

Name of Committee: NIDA Special

Emphasis Panel (Contract Review—‘‘Develop

Prevention Research Dissemination’’).

Date: January 7, 1998.

Time: 9:00 a.m.

Place: Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, MD 20814.

Contact Person: Mr. Lyle Furr, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–42, Rockville, MD 20857,

Telephone (301) 443–1644.

Name of Committee: NIDA Special

Emphasis Panel (Conference Grants).

Date: January 8, 1998.

Time: 9:00 a.m.

Place: National Institute on Drug Abuse,

NIH, NIDA Conference Room 10–05, 5600

Fishers Lane, Rockville, MD 20857.

Contact Person: Dr. William C. Grace,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–42, Rockville, MD 20857,

Telephone (301) 443–2755.

The meetings will be closed in accordance

with provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The

applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the